FdaApplication

ANDA 211975

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTORRENT PHARMA INC
application_typeANDA
approval_date2021-07-26

Products (3)

ProductActive ingredientStrengthDosage form
ERYTHROMYCINERYTHROMYCIN333MGTABLET, DELAYED RELEASE;ORAL
ERYTHROMYCINERYTHROMYCIN250MGTABLET, DELAYED RELEASE;ORAL
ERYTHROMYCINERYTHROMYCIN500MGTABLET, DELAYED RELEASE;ORAL

3 products